用临床研究的优先顺序来纠正黑人癌症的差异

IF 5.1 2区 医学 Q1 ONCOLOGY Cancer Pub Date : 2025-03-05 DOI:10.1002/cncr.35785
Kimlin Ashing PhD, Nadine Barrett PhD, Kim F. Rhoads MD, Folakemi Odedina PhD, Hayley Thompson PhD, Camille Ragin PhD, Timiya S. Nolan PhD, APRN-CNP, Vanessa B. Sheppard PhD
{"title":"用临床研究的优先顺序来纠正黑人癌症的差异","authors":"Kimlin Ashing PhD,&nbsp;Nadine Barrett PhD,&nbsp;Kim F. Rhoads MD,&nbsp;Folakemi Odedina PhD,&nbsp;Hayley Thompson PhD,&nbsp;Camille Ragin PhD,&nbsp;Timiya S. Nolan PhD, APRN-CNP,&nbsp;Vanessa B. Sheppard PhD","doi":"10.1002/cncr.35785","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>People of African ancestry are overrepresented among lives lost prematurely and persons unnecessarily afflicted with the highest burden of cancer among nonindigenous Americans. Amid the growing advancements in cancer discoveries and innovations, the persistence of cancer disparities affecting Black/African American populations is particularly disturbing and disappointing.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Ashing and colleagues in the Alliance of Black Community Outreach and Engagement Scientific Directors of National Cancer Institute–designated cancer centers discuss the excessive cancer burden in Black populations and propose a Cancer Moonshot–focused framework.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>The paper posits for research to remedy cancer disparities, there are three critical areas that require action: (1) examine Black/African American heterogeneity; (2) eradicate policies and practices that are biased toward Black/African American populations and limit access to clinical studies/trials; and (3) embrace community engagement and collaborations.</p>\n </section>\n \n <section>\n \n <h3> Discussion</h3>\n \n <p>This paper extends a call to action focused on eight critical areas for making significant strides to reduce cancer disparities in Black/African American communities: (1) implementation of policies for inclusion, accountability, and coverage; (2) removal of unnecessary barriers to clinical research participation; (3) introduction of continuing clinical research engagement training; (4) broad deployment of provider communication tools and resources for effective patient communication and referrals; (5) diversification of the scientific and clinical workforce; (6) practice of multisectoral and team science; (7) inclusion of community engagement in science; and (8) development of broad and authentic partnerships with our Black/African American communities. Taken together, these pillars support improved engagement with multistakeholder Black/African American communities to close disparities gaps and achieve health equity and justice.</p>\n </section>\n </div>","PeriodicalId":138,"journal":{"name":"Cancer","volume":"131 6","pages":""},"PeriodicalIF":5.1000,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Remedying Black cancer disparities with clinical research prioritization\",\"authors\":\"Kimlin Ashing PhD,&nbsp;Nadine Barrett PhD,&nbsp;Kim F. Rhoads MD,&nbsp;Folakemi Odedina PhD,&nbsp;Hayley Thompson PhD,&nbsp;Camille Ragin PhD,&nbsp;Timiya S. Nolan PhD, APRN-CNP,&nbsp;Vanessa B. Sheppard PhD\",\"doi\":\"10.1002/cncr.35785\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>People of African ancestry are overrepresented among lives lost prematurely and persons unnecessarily afflicted with the highest burden of cancer among nonindigenous Americans. Amid the growing advancements in cancer discoveries and innovations, the persistence of cancer disparities affecting Black/African American populations is particularly disturbing and disappointing.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>Ashing and colleagues in the Alliance of Black Community Outreach and Engagement Scientific Directors of National Cancer Institute–designated cancer centers discuss the excessive cancer burden in Black populations and propose a Cancer Moonshot–focused framework.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>The paper posits for research to remedy cancer disparities, there are three critical areas that require action: (1) examine Black/African American heterogeneity; (2) eradicate policies and practices that are biased toward Black/African American populations and limit access to clinical studies/trials; and (3) embrace community engagement and collaborations.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Discussion</h3>\\n \\n <p>This paper extends a call to action focused on eight critical areas for making significant strides to reduce cancer disparities in Black/African American communities: (1) implementation of policies for inclusion, accountability, and coverage; (2) removal of unnecessary barriers to clinical research participation; (3) introduction of continuing clinical research engagement training; (4) broad deployment of provider communication tools and resources for effective patient communication and referrals; (5) diversification of the scientific and clinical workforce; (6) practice of multisectoral and team science; (7) inclusion of community engagement in science; and (8) development of broad and authentic partnerships with our Black/African American communities. Taken together, these pillars support improved engagement with multistakeholder Black/African American communities to close disparities gaps and achieve health equity and justice.</p>\\n </section>\\n </div>\",\"PeriodicalId\":138,\"journal\":{\"name\":\"Cancer\",\"volume\":\"131 6\",\"pages\":\"\"},\"PeriodicalIF\":5.1000,\"publicationDate\":\"2025-03-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.35785\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer","FirstCategoryId":"3","ListUrlMain":"https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.35785","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

在非土著美洲人中,过早死亡和不必要地遭受最高癌症负担的人群中,非洲血统的人所占比例过高。随着癌症发现和创新的不断进步,影响黑人/非裔美国人的癌症差异的持续存在尤其令人不安和失望。方法ash和他在美国国家癌症研究所指定癌症中心的黑人社区外展和参与联盟的同事们讨论了黑人人口过度的癌症负担,并提出了一个以癌症登月计划为重点的框架。结果:本文认为,为了弥补癌症差异,有三个关键领域需要采取行动:(1)研究黑人/非裔美国人的异质性;(2)消除对黑人/非裔美国人的偏见和限制临床研究/试验的政策和做法;(3)拥抱社区参与和合作。本文呼吁在减少黑人/非裔美国人社区癌症差异方面取得重大进展的八个关键领域采取行动:(1)实施包容、问责和覆盖政策;(2)消除参与临床研究的不必要障碍;(3)引入持续临床研究参与培训;(4)广泛部署提供者沟通工具和资源,以有效地与患者沟通和转诊;(5)科学和临床工作人员的多样化;(6)多部门、团队科学实践;(7)纳入社区参与科学;(8)与我们的黑人/非裔美国人社区发展广泛而真诚的伙伴关系。综合起来,这些支柱支持加强与多利益攸关方黑人/非洲裔美国人社区的接触,以缩小差距,实现卫生公平和正义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Remedying Black cancer disparities with clinical research prioritization

Background

People of African ancestry are overrepresented among lives lost prematurely and persons unnecessarily afflicted with the highest burden of cancer among nonindigenous Americans. Amid the growing advancements in cancer discoveries and innovations, the persistence of cancer disparities affecting Black/African American populations is particularly disturbing and disappointing.

Methods

Ashing and colleagues in the Alliance of Black Community Outreach and Engagement Scientific Directors of National Cancer Institute–designated cancer centers discuss the excessive cancer burden in Black populations and propose a Cancer Moonshot–focused framework.

Results

The paper posits for research to remedy cancer disparities, there are three critical areas that require action: (1) examine Black/African American heterogeneity; (2) eradicate policies and practices that are biased toward Black/African American populations and limit access to clinical studies/trials; and (3) embrace community engagement and collaborations.

Discussion

This paper extends a call to action focused on eight critical areas for making significant strides to reduce cancer disparities in Black/African American communities: (1) implementation of policies for inclusion, accountability, and coverage; (2) removal of unnecessary barriers to clinical research participation; (3) introduction of continuing clinical research engagement training; (4) broad deployment of provider communication tools and resources for effective patient communication and referrals; (5) diversification of the scientific and clinical workforce; (6) practice of multisectoral and team science; (7) inclusion of community engagement in science; and (8) development of broad and authentic partnerships with our Black/African American communities. Taken together, these pillars support improved engagement with multistakeholder Black/African American communities to close disparities gaps and achieve health equity and justice.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cancer
Cancer 医学-肿瘤学
CiteScore
13.10
自引率
3.20%
发文量
480
审稿时长
2-3 weeks
期刊介绍: The CANCER site is a full-text, electronic implementation of CANCER, an Interdisciplinary International Journal of the American Cancer Society, and CANCER CYTOPATHOLOGY, a Journal of the American Cancer Society. CANCER publishes interdisciplinary oncologic information according to, but not limited to, the following disease sites and disciplines: blood/bone marrow; breast disease; endocrine disorders; epidemiology; gastrointestinal tract; genitourinary disease; gynecologic oncology; head and neck disease; hepatobiliary tract; integrated medicine; lung disease; medical oncology; neuro-oncology; pathology radiation oncology; translational research
期刊最新文献
Cost-effectiveness of vorasidenib in treatment of isocitrate dehydrogenase-mutated low-grade glioma. Efficacy and safety of elranatamab in patients with relapsed or refractory multiple myeloma: A US subgroup analysis from MagnetisMM-3. Integration of venetoclax into a fludarabine and melphalan conditioning regimen in patients aged 50 years and older with acute myeloid leukemia and myelodysplastic syndrome: Results from a phase 2 clinical trial. Bridging the gap to improve skin cancer prevention practices in childhood cancer survivors. Understudied and overlooked: Addressing sexual quality of life for couples facing metastatic breast cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1